Results 211 to 220 of about 156,286 (339)
Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment
What's New? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas +9 more
wiley +1 more source
Molecular profiles of the great obstetrical syndromes reveal common features and dynamic changes in early pregnancy. [PDF]
Zeng X +8 more
europepmc +1 more source
The Obstetrical Society of London and the Midwives Question: Being an Abstract of the Inaugural Address delivered before the Society on March 6th, 1895 [PDF]
Francis Henry Champneys
openalex +1 more source
What's New? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo +6 more
wiley +1 more source
Access to Limited Critical Care and Risk of Mortality in Rwanda: A Prospective Cohort Study. [PDF]
Mezei A +7 more
europepmc +1 more source
What's New? Human papillomavirus (HPV) assays currently used in cervical cancer screening detect genotypes without providing information on viral lineages and sublineages. However, genotype‐specific sublineages may have distinct risk profiles, which could be harnessed to further improve risk stratification.
Karoline Andersen +8 more
wiley +1 more source
Emergency department visits among First Nations female adults in Alberta: a population-based study. [PDF]
LaPlante E +9 more
europepmc +1 more source

